What We Do

Med-ERRS uses Failure Mode & Effects Analysis (FMEA) for evaluating medication names, package, and labels. We also employ other evaluative techniques and methodologies recommended by the US Food and Drug Administration, as well as other regulatory authorities.

Med-ERRS tests proposed trademarks in the pre-marketing phase for new drug products to identify and prevent potential look-alike and sound-alike confusion with existing products. In addition, Med-ERRS evaluates the design of drug packaging and labels to maximize safety during use. Our consultative services are provided to pharmaceutical, biotechnology and technology companies in need of expert review, evaluation and direction on the safe use of their products. Besides pre-marketing services, Med-ERRS also works with pharmaceutical companies to provide post-marketing services that analyze potential and actual medication errors.